Evan Rachlin, MD, is Co-Founder and Managing Partner of Ascenta Capital. Prior to Ascenta, he was a Managing Director in Blackstone Life Sciences. Previously, Dr. Rachlin worked at Moderna, Bain Capital, McKinsey & Company and Pfizer. Dr. Rachlin earned an MD from Harvard Medical School, MBA from Harvard Business School, and AB magna cum laude from Harvard College with a concentration in Biochemistry and a citation in Japanese.